Pembrolizumab Alone or With Chemotherapy for 70+ Year-Old Lung Cancer Patients: A Retrospective Study
Miriam Blasi, Jonas Kuon, Rajiv Shah, Farastuk Bozorgmehr, Florian Eichhorn, Stephan Liersch, Albrecht Stenzinger, Claus Peter Heußel, Felix Herth, Michael Thomas, Petros Christopoulos
Topics & Concepts
MedicinePembrolizumabInternal medicineLung cancerAdverse effectDiscontinuationChemotherapyHazard ratioCommon Terminology Criteria for Adverse EventsRetrospective cohort studyCancerGastroenterologyOncologySurgeryConfidence intervalImmunotherapyCancer Immunotherapy and BiomarkersLung Cancer Diagnosis and TreatmentLung Cancer Research Studies